CN1742755A - 一种红曲提取物及其制剂 - Google Patents
一种红曲提取物及其制剂 Download PDFInfo
- Publication number
- CN1742755A CN1742755A CN 200510011056 CN200510011056A CN1742755A CN 1742755 A CN1742755 A CN 1742755A CN 200510011056 CN200510011056 CN 200510011056 CN 200510011056 A CN200510011056 A CN 200510011056A CN 1742755 A CN1742755 A CN 1742755A
- Authority
- CN
- China
- Prior art keywords
- monas cuspurpureus
- cuspurpureus went
- extract
- temperature
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940057059 monascus purpureus Drugs 0.000 title claims description 59
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000012138 yeast extract Substances 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 48
- 239000000843 powder Substances 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000007787 solid Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 244000113306 Monascus purpureus Species 0.000 claims description 57
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 239000003814 drug Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 238000001035 drying Methods 0.000 abstract description 9
- 239000012141 concentrate Substances 0.000 abstract description 8
- 238000000605 extraction Methods 0.000 abstract description 3
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 25
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 22
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 20
- 229960004844 lovastatin Drugs 0.000 description 18
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 6
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 5
- 239000007901 soft capsule Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 206010013786 Dry skin Diseases 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940099246 mevacor Drugs 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 2
- 229960002855 simvastatin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000008802 xuezhikang Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000152526 Agathosma crenulata Species 0.000 description 1
- 235000013388 Agathosma crenulata Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 235000009269 Barosma crenulata Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000002402 anti-lipaemic effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940062650 buchu Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- AGNDLYBQPUJADV-VCWNUMGPSA-N dihydromonacolin L Chemical compound C([C@@H]1[C@H]2CC[C@H](C[C@@H]2C=C[C@@H]1C)C)C[C@@H]1C[C@@H](O)CC(=O)O1 AGNDLYBQPUJADV-VCWNUMGPSA-N 0.000 description 1
- AGNDLYBQPUJADV-UHFFFAOYSA-N dihydromonacolin L Natural products CC1C=CC2CC(C)CCC2C1CCC1CC(O)CC(=O)O1 AGNDLYBQPUJADV-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- QLJODMDSTUBWDW-BXMDZJJMSA-N mevinolinic acid Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C=C21 QLJODMDSTUBWDW-BXMDZJJMSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- ZDFOBOYQVYMVCW-IRUSZSJRSA-N monacolin J Chemical compound C([C@@H]1[C@H]2[C@@H](O)C[C@H](C=C2C=C[C@@H]1C)C)C[C@@H]1C[C@@H](O)CC(=O)O1 ZDFOBOYQVYMVCW-IRUSZSJRSA-N 0.000 description 1
- XXKNHBAFFJINCK-RVEJDSBJSA-N monascin Chemical compound C([C@@H]1[C@H](C(O[C@@]1(C)C1=O)=O)C(=O)CCCCC)C2=C1COC(\C=C\C)=C2 XXKNHBAFFJINCK-RVEJDSBJSA-N 0.000 description 1
- GFSMXLMQRWMHON-UHFFFAOYSA-N monascin Natural products CCCCCC(=O)C1C2C=C3C=C(OC=C3C(=O)C2(C)OC1=O)C=CC GFSMXLMQRWMHON-UHFFFAOYSA-N 0.000 description 1
- GIKQHOXMDCDAPT-UHFFFAOYSA-N monascusone B Natural products CC=CC1=CC2=C(CO1)C(=O)C3(C)OC(=O)C(C3C2)C(=O)C GIKQHOXMDCDAPT-UHFFFAOYSA-N 0.000 description 1
- ZDFOBOYQVYMVCW-UHFFFAOYSA-N monocolin J Natural products CC1C=CC2=CC(C)CC(O)C2C1CCC1CC(O)CC(=O)O1 ZDFOBOYQVYMVCW-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical group [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100110568A CN100342861C (zh) | 2005-10-11 | 2005-10-11 | 一种红曲提取物及其制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100110568A CN100342861C (zh) | 2005-10-11 | 2005-10-11 | 一种红曲提取物及其制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1742755A true CN1742755A (zh) | 2006-03-08 |
CN100342861C CN100342861C (zh) | 2007-10-17 |
Family
ID=36138380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100110568A Active CN100342861C (zh) | 2005-10-11 | 2005-10-11 | 一种红曲提取物及其制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100342861C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101584716B (zh) * | 2009-04-10 | 2012-05-23 | 昆明法莫泰克生物技术有限公司 | 红曲提取物油及其软胶囊的制备和应用 |
CN102617533A (zh) * | 2011-02-01 | 2012-08-01 | 北京北大维信生物科技有限公司 | 一种从红曲中分离的化合物、其制备方法及用途 |
CN101313919B (zh) * | 2007-05-31 | 2012-08-08 | 北京北大维信生物科技有限公司 | 一种红曲提取物及其制备方法和质量检测方法 |
CN105560993A (zh) * | 2016-01-20 | 2016-05-11 | 青岛自然珍萃生物科技有限公司 | 一种高效渗漉提取红曲提取物的方法及其提取物的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1123327A (zh) * | 1994-09-13 | 1996-05-29 | 张永权 | 高色价水溶性红曲红色素的制造方法 |
CN1052386C (zh) * | 1997-05-23 | 2000-05-17 | 尤新 | 一种具有降糖、降脂、降压作用的功能食品 |
-
2005
- 2005-10-11 CN CNB2005100110568A patent/CN100342861C/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101313919B (zh) * | 2007-05-31 | 2012-08-08 | 北京北大维信生物科技有限公司 | 一种红曲提取物及其制备方法和质量检测方法 |
CN101584716B (zh) * | 2009-04-10 | 2012-05-23 | 昆明法莫泰克生物技术有限公司 | 红曲提取物油及其软胶囊的制备和应用 |
CN102617533A (zh) * | 2011-02-01 | 2012-08-01 | 北京北大维信生物科技有限公司 | 一种从红曲中分离的化合物、其制备方法及用途 |
CN103339121A (zh) * | 2011-02-01 | 2013-10-02 | 北京北大维信生物科技有限公司 | 一种从红曲中分离的化合物、其制备方法及用途 |
CN102617533B (zh) * | 2011-02-01 | 2014-08-27 | 北京北大维信生物科技有限公司 | 一种从红曲中分离的化合物、其制备方法及用途 |
CN103339121B (zh) * | 2011-02-01 | 2016-04-13 | 北京北大维信生物科技有限公司 | 一种从红曲中分离的化合物、其制备方法及用途 |
CN105560993A (zh) * | 2016-01-20 | 2016-05-11 | 青岛自然珍萃生物科技有限公司 | 一种高效渗漉提取红曲提取物的方法及其提取物的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100342861C (zh) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101297880B (zh) | 含根皮苷的活性提取物及其用途 | |
CN105395919B (zh) | 一种含有黑木耳提取物、具有降血脂作用的组合物及其制备方法 | |
CN1257724C (zh) | 一种预防和治疗糖尿病的组合物 | |
CN100342861C (zh) | 一种红曲提取物及其制剂 | |
CN101033245A (zh) | 具栖冬青苷的制备方法及应用 | |
CN102697982B (zh) | 一种具有辅助降血脂功能的组合物及其制备方法 | |
CN101843627B (zh) | 二氢菲苷类化合物在制备防治心脑血管疾病药物中的应用 | |
CN101028328A (zh) | 柿叶提取物的制备及应用 | |
CN1274684C (zh) | 蜂胶黄酮提取物的制备方法、药物制剂及医药新用途 | |
CN1709451A (zh) | 一种用于治疗肝胆疾病的的叶下珠制剂及其制备方法 | |
CN1293874C (zh) | 以洛伐他汀盐为主要活性成分的中药红曲及其制剂 | |
CN101584716B (zh) | 红曲提取物油及其软胶囊的制备和应用 | |
CN100350899C (zh) | 冠心丹参双相胶囊及其制备方法 | |
CN1966481A (zh) | 一种丹参水溶性提取物盐及其制备方法 | |
CN1686141A (zh) | 一种治疗肝炎和糖尿病的药物组合物 | |
CN1159029C (zh) | 一种调脂药物及其制备方法 | |
CN1212143C (zh) | 一种治疗冠心病的药物及其制备方法 | |
CN1202836C (zh) | 蟾衣制剂及其生产工艺 | |
CN101773529B (zh) | 一种治疗心脑血管疾病的中药组合物及其制剂 | |
CN111166847B (zh) | 一种含姜黄的药物组合物及其片剂和制备方法 | |
CN1431215A (zh) | 制备保肝降脂药物白藜芦醇甙及由其制备保肝降脂药物的方法 | |
NL2031313B1 (en) | Compound formulation with blood lipid-lowering effects and preparation method thereof | |
CN101444547A (zh) | 一种沙棘提取物微丸及其制备方法 | |
CN1589845A (zh) | 山楂总酚酸部位的制备工艺和应用 | |
CN1202846C (zh) | 一种通络降脂药物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Li Chaohui Assignor: YUNNAN YONGAN PHARMACEUTICAL CO., LTD. Contract record no.: 2010530000061 Denomination of invention: Red-yeast extract and preparation therefor Granted publication date: 20071017 License type: Exclusive License Open date: 20060308 Record date: 20101102 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: YUNNAN YONGAN PHARMACEUTICAL CO., LTD. Assignor: Li Chaohui Contract record no.: 2010530000061 Denomination of invention: Red-yeast extract and preparation therefor Granted publication date: 20071017 License type: Exclusive License Open date: 20060308 Record date: 20101102 |
|
ASS | Succession or assignment of patent right |
Owner name: KUNMING FAMOTAIKE BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LI ZHAOHUI Effective date: 20150603 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650200 KUNMING, YUNNAN PROVINCE TO: 650106 KUNMING, YUNNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150603 Address after: Two, No. four, No. 402-1, building A2, 650106, University Science Park, Kunming hi tech Development Zone, Yunnan, China Patentee after: Kunming Famotaike Biotechnology Co., Ltd. Address before: 650200 room 1, unit 6, 301 Yuan Yuan community, Kunming, Yunnan Patentee before: Li Chaohui |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151228 Address after: Qujing City, Yunnan province 655000 kylin District Jianning Road Patentee after: YUNNAN YONGAN PHARMACEUTICAL CO., LTD. Address before: Two, No. four, No. 402-1, building A2, 650106, University Science Park, Kunming hi tech Development Zone, Yunnan, China Patentee before: Kunming Famotaike Biotechnology Co., Ltd. |